InsidersTradesSigma
Track the 国药现代 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 国药现代 has published 3 public disclosures. Market capitalisation: €11.7bn. The latest transaction was filed on 12 April 2023 (Purchase). Among the most active insiders: 李显林. Every trade is openly available.
3
Insider Decl.
n/a
Thresholds
€36,249
3 ops.
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,617 of 28,855 companies
74.8
score / 100
Value85
Quality65
FCF yld12%
Earn yld8.1%
EV/EBITDA5.7x
ROE5.7%
Gross mgn32%
Net mgn10%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 April 2023
About 国药现代
Guoyao Modern is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and distribution of pharmaceutical products.